Vascular Biology |
From the Unit of Vascular Biology (V.A., E.P.), Instituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas, Valencia, Spain; and Department of Medicine (Cardiology) (J.U., D.C., D.G.), St Elizabeths Medical Center, Tufts University School of Medicine, Boston, Mass. Dr Goukassians present address is Department of Dermatology, Boston University School of Medicine, Boston, Mass.
Correspondence to Dr Vicente Andrés, Instituto de Biomedicina, Consejo Superior de Investigaciones Científicas, C/ Jaime Roig 11, 46010 Valencia, Spain. E-mail vandres{at}ibv.csic.es
AbstractThe abnormal proliferation of vascular smooth muscle cells (VSMCs) plays an important role in atherosclerosis and restenosis. Although several studies have implicated the growth inhibitory protein p27Kip1 (p27) in the control of myocyte growth and hypertrophy, little is known about the molecular mechanisms that regulate p27 expression in the cardiovascular system. In the present study, we demonstrate the interaction of the transcription factor Sp1 with 2 GC-rich sequences within the p27 promoter in cultured VSMCs. Importantly, point mutations that disrupted Sp1 binding markedly reduced p27 promoter activity, demonstrating that Sp1 is required for efficient p27 gene transcription in cultured VSMCs. Because p27 expression is upregulated after balloon angioplasty, we investigated Sp1 expression and activity in control and balloon-injured rat carotid arteries to assess the role of Sp1 as a physiological regulator of p27 expression. Although immunohistochemical analysis disclosed Sp1 protein expression in both control and balloon-injured arteries, a high level of Sp1 DNA-binding activity was found only in response to balloon angioplasty. Collectively, these results demonstrate that Sp1 is essential for maximum p27 promoter activity in VSMCs and suggest that posttranslational induction of Sp1 DNA-binding activity contributes to the induction of p27 expression and VSMC growth arrest at late time points after balloon angioplasty.
Key Words: vascular smooth muscle cell cell cycle Sp1 p27 angioplasty
This article has been cited by other articles:
![]() |
L. Hammoud, D. E. Burger, X. Lu, and Q. Feng Tissue inhibitor of metalloproteinase-3 inhibits neonatal mouse cardiomyocyte proliferation via EGFR/JNK/SP-1 signaling Am J Physiol Cell Physiol, April 1, 2009; 296(4): C735 - C745. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Deaton, Q. Gan, and G. K. Owens Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1027 - H1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Fischer, S. Zheng, R. Fan, and J. A. Voynow Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1 Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L762 - L768. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inafuku, T. Toda, T. Okabe, A. Shinjo, H. Iwasaki, and H. Oku Expression of Cell-Cycle-Regulating Genes in the Development of Atherosclerosis in Japanese Quail (Coturnix japonica) Poult. Sci., June 1, 2007; 86(6): 1166 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Diez-Juan and V. Andres Coordinate Control of Proliferation and Migration by the p27Kip1/Cyclin-Dependent Kinase/Retinoblastoma Pathway in Vascular Smooth Muscle Cells and Fibroblasts Circ. Res., March 7, 2003; 92(4): 402 - 410. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |